Arena Pharmaceuticals Inc (ARNA) EVP, Head of R&D, and CMO Christopher Cabell Sold $884,000 of Shares

Author's Avatar
Jul 17, 2020
Article's Main Image

EVP, Head of R&D, and CMO of Arena Pharmaceuticals Inc (30-Year Financial, Insider Trades) Christopher Cabell (insider trades) sold 13,000 shares of ARNA on 07/15/2020 at an average price of $68 a share. The total sale was $884,000.

Arena Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs. Arena Pharmaceuticals Inc has a market cap of $3.88 billion; its shares were traded at around $68.51 with and P/S ratio of 617.20. GuruFocus has detected 4 severe warning signs with Arena Pharmaceuticals Inc. .

Directors and Officers Recent Trades:

  • EVP, Head of R&D, and CMO Christopher Cabell sold 13,000 shares of ARNA stock on 07/15/2020 at the average price of $68. The price of the stock has increased by 0.75% since.

For the complete insider trading history of ARNA, click here

.